Audited Financial Results for the quarter and year ended 31.03.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Chemcrux Enterprises reported audited standalone results for FY2026 with revenue from operations of Rs 8,257.92 Lacs, up 17.5% from Rs 7,025.39 Lacs in FY2025. Standalone Profit After Tax grew significantly to Rs 544.97 Lacs from Rs 418.86 Lacs, representing 30.1% growth. The Board recommended a 10% dividend (Rs 1 per share). On consolidated basis, revenue was Rs 8,064.64 Lacs with PAT of Rs 373.08 Lacs, down from Rs 391.30 Lacs due to subsidiary Kalichem Private Limited losses. The subsidiary commenced commercial production in November 2024 and became a wholly-owned subsidiary in February 2025. Auditors issued unmodified opinions on both standalone and consolidated financial statements.
Standalone performance is strong with 30% PAT growth, indicating healthy core operations. However, consolidated EPS declined sharply due to subsidiary losses, which investors should monitor. The company maintained positive operating cash flows of Rs 1,385.24 Lacs.